FDA approved 1,000+ diagnostic AI devices. But most AI tools physicians use daily—clinical scribes, workflow automation, RCM—require zero oversight. As a gastroenterologist and AI early adopter, I've been guilty: I demand Phase III trials for IBD meds but deployed AI scribes after a demo. This explores the two-tier reality, why evidence-based standards matter, and questions to ask before adopting any AI tool that influences patient care. Because "good enough" isn't good enoug
